Wikidata

(Q62105012)

English

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

clinical trial

In more languages

Statements

title
Phase II Study of Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Patients With Previously Untreated High-Risk or Relapsed or Refractory Multiple Myeloma (English)
0 references
medical condition
multiple myeloma
0 references
plasmacytoma
0 references
number of participants
0
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
thalidomide
0 references
arsenic trioxide
0 references
sodium ascorbate
0 references
mitogens
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105012&oldid=2035753736"